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who are heterozygous for a mutation that alters one or another constituent of the extracellular matrix.1-3 Recently, the major fibrillar collagens were excluded as the site of the fundamental defect in a number of larger families,4,5 and attention has focused on elastic fibers,6 8 especially the microfibrillar fiber component. 9 The latter are ubiquitous in tissues of the body,10 and if proved to be defective, the pleiotropic manifestations of Marfan's syndrome will be readily explained. In particular, elastic fibers are ordinarily prominent in the aortic media but appear disorganized and fragmented in aortic specimens from patients with Mar- fan's syndrome. The biochemical defect presumably renders the aorta susceptible to dilatation and dissection, which together have led to early demise of more than 90% of patients."
Prophylactic repair of the aorta with a composite valve and graft is effective therapy once the ascending aorta becomes widely dilated.12'13 Based on experience in animals susceptible to aortic dissection14 and with pharmacologic therapy of acute aortic dissection in humans, 15 it was proposed that the Marfan aorta could be protected by reducing the inotropic state of the left ventricle and the subsequent impact of ejected blood.16 A controlled trial suggested that both the rate of aortic dilatation and the occurrence of dissection were reduced by negative-inotropic doses of propranolol during 5-8 years. 17 However, neither direct measures of biomechanical properties of the Marfan aorta nor of the hemodynamic responses to fB-adrenergic receptor blockade in patients with Marfan's syndrome have been reported.
The aortic input impedance is a means of quantifying both the steady-state and pulsatile hemodynamic load imposed by the arterial system on the heart.'8 The steady-state load is determined by total arterial resistance, whereas the pulsatile load is determined largely by compliance, reflection, and wave transmission properties of the proximal aorta. Aortic impedance has been described in healthy humans at rest and during physiologic maneuvers19-27 and in patients with heart failure.25,28 Impedance and compliance changes in patients with hypertension have been recently reported.26,27'29-31 Neither aortic impedance nor compliance have been measured, however, in patients with Marfan's syndrome despite the predilection of this disease to involve the ascending aorta. Moreover, despite the apparent clinical efficacy of f3-adrenergic blocking agents, their detailed effects on arterial hemodynamic indexes in this disease have also not been examined. The aim of this study was to determine aortic input impedance and compliance in patients with Marfan's syndrome in the baseline state and after short-term /3-blockade with intravenous propranolol.
Methods

Protocol
Patients selected for study had a diagnosis of Marfan's syndrome based on history and physical examination.1"3 All were referred for diagnostic cardiac catheterization because of progressive dilatation of the ascending aorta as evidenced by echocardiography on serial examinations. None of the patients had hemodynamically significant aortic regurgitation at the time of study. This was ascertained in each patient by noting that the aortic pulse pressure did not differ from the normal range and by examination of the flow velocity tracing to ensure that reversal of flow was confined to the early diastolic period and that the middle and late diastolic flow remained at the baseline value without large positive or negative fluctuations (see below). Two patients (2 and 6) had not yet received any /3-blocking agents before study. Patients who had been receiving /3-blocking agents had them withheld before study (three patients for 24 hours and the remaining patients for 48 hours or more). The study protocol was approved by an Institutional Review Committee, and informed consent was obtained for the study from each patient.
All patients were studied after routine diagnostic catheterization that included premedication with diazepam (10 mg p.o.) and diphenhydramine (50 mg p.o.) and aortography with sodium diatrozoate. After completing the diagnostic portion of the catheterization, a 7F multi-sensor catheter (VPC-683C, Millar Instruments, Houston, Texas) was advanced through a femoral artery sheath to the ascending aorta. This catheter had two micromanometers, one at the tip and one 6 cm proximal to the tip, and an electromagnetic flow velocity sensor 2 cm proximal to the proximal pressure sensor. Attempts were made to advance the tip of the catheter retrograde across the aortic valve so that it could be held by the leaflets in the center of the root28 to minimize motion artifacts. A simultaneous left ventricular and aortic pressure waveform confirmed this position. We were not successful in crossing the valve, however, in four patients (1, 2, 5, and 9) because of the dilated root. In these patients, the catheter was positioned with the distal tip as close as possible to the valve leaflets. This was done to minimize catheter motion during the cardiac cycle and also to position the flow sensor proximal to the origin of the great vessels. This position was verified by fluoroscopy several times during the course of the study. Once the catheter was in position, ascending aorta pressure and flow were recorded on FM tape (3968A, Hewlett-Packard, Andover, Massachusetts) for offline analysis. The first recording, made while the patient was resting quietly, was considered the baseline measurement and was made at least 30 minutes after the last injection of contrast agent. Intravenous nitroprusside was then begun at 0.25 mg/kg/min and increased every 3-5 minutes until peak aortic pressure had decreased by 15% from its baseline value or had fallen to 90 mm Hg. Recordings were then repeated. The nitroprusside infusion was then stopped, and the patient was immediately given intravenous propranolol (0.15 mg/kg) during several minutes. Recordings were repeated 10 minutes after completing this drug administration. In five patients, recordings were made during nitroprusside infusion after propranolol.
Data Analysis
From the pressure and flow velocity signals, aortic impedance was calculated with methods previously described.28 Briefly, the aortic root diameter just above the valves was measured by echocardiography at the time of catheterization, and aortic volume flow was calculated by multiplying the flow velocity by the aortic cross-sectional area. The ascending aortic pressure and flow signals were digitized at a sampling frequency of 250 Hz and displayed on a monitor. Only flow data that were free of impact artifacts and that showed a very early diastolic flow reversal with no major undulations in middle through late diastole were considered suitable for analysis. The pressure and flow signals for each suitable beat were resolved into their first 10 Fourier harmonics with software that had been previously developed in our laboratory. As previously reported, we then obtained a rough estimate of the noise level of the flow velocity signal by performing Fourier analysis of the late diastolic portion of the signal. Only flow harmonics that exceeded twice the value of the harmonic with the highest modulus were retained for analysis.28 From these data, we calculated stroke volume, the harmonics of impedance modulus and phase, the oscillatory and total power, the peak velocity, and the first zero-crossing of the impedance phase angle (by linear interpolation). To obtain an indication of the impact forces of the blood on the aorta wall, the velocity signal was differentiated with a fivepoint interpolation algorithm, and the maximum blood acceleration was calculated. In addition, an index of the magnitude of wave reflection was obtained by resolving the pressure wave into its forward and backward components32 and by calculating the ratio of the backward to forward components. 33 The data from at least five suitable, nonconsecutive beats were averaged for a given condition. For those patients in whom the catheter could not be passed across the aortic valve, obtaining suitable beats often required examining many beats (in some patients, 50 or more) before at least five suitable beats could be found. Of note, we did not correct the impedance phase angle for the small 2-cm spacing between the pressure and flow sensors. By assuming a wave velocity of 500 cm/ sec in the ascending aorta, this spacing would result in an error of about 1.4 times frequency in impedance phase angle.34 Because we only used the phase angle to estimate the zero crossing of phase, which occurs at low frequencies and requires linear interpolation anyway, this small correction was deemed unnecessary.
Total arterial compliance was estimated with a slight modification of the method recently proposed. 35 This method assumes that the circulation can be described in terms of a two-element Windkessel model and uses the area under the aortic pressure-time curve rather than previously described methods.29-31 Our method should be less susceptible to noise and other artifacts due to, for example, late wave reflections. In addition, by assuming a specific functional form for the arterial pressurevolume relation, direct determination of the pressure dependence of compliance is possible. We assumed that the pressure-volume relation is an exponential function of the form V=aebP (1) where a and b are the experimentally determined coefficients that best fit the pressure-volume data from isolated arteries. The compliance is dependent upon only the coefficient b in the pressure-volume relation. The expression for arterial compliance at any pressure is
-(e where SV is stroke volume, Zc is the characteristic impedance, K is the ratio of the entire area to the diastolic area under the pressure-time curve, Ad is the diastolic area under the pressure-time curve, and ps* and Pd are the dicrotic notch and enddiastolic aortic pressures, respectively.
We have recently shown that the coefficient b is nearly constant and equal to about -0.01 in several different human large arteries.35 In addition, coefficient b has essentially the same value for several mammalian species and is not significantly affected by vasodilation with nitroprusside (unpublished data from this laboratory). Consequently, we used a value of -0.01 for all our estimates of compliance in this study. 
Results
The clinical characteristics of all the patients are summarized in Table 1 . Ten patients qualified for the study, but only nine had data of sufficient quality for analysis in the resting state. From these nine patients, two subsets were identified. One subset consisted of seven patients (1-7) with usable data during nitroprusside infusion. A separate subset of seven patients (1-5, 8, and 9) was given the /3-blocker. Of these seven patients, five (1) (2) (3) (4) (5) were also given nitroprusside after the /3-blocker.
Representative ascending aortic pressure and flow waveforms for a patient (5) during baseline and after ,3-blockade are shown in Figure 1 . The corresponding impedance modulus and phase plots during baseline, nitroprusside, after /-blockade, and /3-blocker with nitroprusside for this patient are shown in Figure 2 . Of note, data are missing at one frequency after ,B-blockade. The reason for this is that the flow data at that frequency fell below our noise criteria and were thus eliminated. The data on either side of this frequency were connected with a straight line. We believe this provides a more reliable estimate of the impedance spectrum than if no noise exclusion criterion were used, and data at all frequencies were shown. The impedance moduli for all the patients, averaged in 1-Hz frequency intervals, during baseline, nitroprusside, /-blockade, and combined nitroprusside and /3-blockade are shown in Figure 3 .
The baseline hemodynamic data for each patient are summarized in Table 2 . The major difference in these data from those reported in other normal populations19-27 is the elevated reflection index. The variability in all of the indexes is of a magnitude similar to observations in previous studies from our and other laboratories.'9-28 The results of each of the drug interventions are summarized in Table 3 HR, heart rate (beats/min); SV, stroke volume (cc); Vel, maximum flow velocity (cm/sec); Accel, maximum flow acceleration (cm/sec/ sec); R and Z7, total vascular resistance and characteristic impedance (dynes-sec/cm5), respectively; Wt and W., total and oscillatory external power (mW), respectively; Pf and Pb, forward and backward components of pressure wave (mm Hg), respectively; fo, first zero crossing of impedance phase angle (Hz). *Statistical analysis performed using paired t tests Nevertheless, we can make some reasonable interpretations about the compliance changes induced in a given individual by the drugs. The finding that nitroprusside increased compliance from its baseline values is not surprising. First, the passive effect of decreasing pressure should increase arterial compliance. In addition, there may be a component of active vasodilatation of the smooth muscle to further decrease the compliance. The magnitude of the change is quite large and may reflect the very large volume contained in the dilated root in this disease.
The decrease in compliance compared with the baseline state after ,3-blockade, however, probably cannot be ascribed to passive pressure changes. As shown in Table 4 , the decrease in compliance between baseline and fl-blockade (at all three pressures) was about the same size as the differences in compliances between systolic and mean or mean and diastolic pressures in each state. The pressure increases induced by fl-blockade were, however, much smaller than these pressure fluctuations within a beat. Thus, an active process such as unmasked smooth muscle tone, which was discussed in conjunction with increased wave reflection, could also be playing a role in the compliance changes.
One surprising finding was that peak flow acceleration was not reduced after fl-blockade. As discussed earlier, reduction of the impact force of the blood on the dilated aortic wall is one of the therapeutic rationales for using fl-blockade in this disease. Our data indicate, however, that this was not the case, at least with short-term fl-blockade with propranolol. One may argue that we found no effect of propranolol because we did not give a sufficient dose or because some patients had a residual effect of long-term fl-blockade that muted the impact of additional drug. The heart rate decrease of 8 beats/min before and after propranolol (Table  3) , though small, is within the range of 5-17 beats/ min reported in other human studies41-44 in which a clear hemodynamic effect of propranolol was found. In addition, in three patients (all of whom had previously received long-term propranolol) in whom we were able to measure left ventricular pressures, we found an average decrease in maximum left ventricular dP/dt of 16% after propranolol administration. The magnitude of this decrease is comparable to the 11% decrease in maximum left ventricular dP/dt found after a large dose of short-term intravenous propranolol (1 mg/kg) in chronically instrumented dogs. 45 Finally, we found a significant eflect of propranolol to increase the already elevated wave reflection index. A similar effect occurred in a previous study in a group of hypertensive patients. 28 Thus, from chronotropic, inotropic, and wave reflection standpoints, reasonable evidence exists that our dose of propranolol produced a physiologic effect. Therefore, from several standpoints, our results indicate that short-term fl-blockade in an already dilated aorta, rather than being efficacious in reducing aortic root stress, may be deleterious. It appears to increase wave reflections, thereby perhaps imposing an additional load on the heart18,40; it does not decrease the acceleration of blood in the aortic root, and it decreases arterial compliance, thereby also increasing the load on the vessel wall and heart. Therefore, the desirability of using propranolol for P3-blockade in this setting deserves more careful reexamination. If these findings are confirmed in future studies, perhaps consideration should be given to the use of a more selective cardiac P-blocking agent that is without significant peripheral effects.
Limitations of the Study
Certain limitations of this study should be kept in mind. Because the flow transducer that we used measured flow velocity rather than volume flow, the volume flow-dependent indexes (stroke volume, impedance, resistance, etc.) were calculated by assuming that no significant alterations occurred in aortic root diameter during any phase of the study. Echocardiography was performed during each phase of the study in the first few patients in this study. In no patient did we observe any effect of the drugs on aortic diameter. Consequently, this measurement was not made repeatedly in the remaining patients. Our previous experience in patients with heart failure in whom arterial pressure was lowered by nitroprusside by about the same degree as in the present study also indicated that no significant alterations occurred in aortic diameter, even though these were results in aortas of normal size.28 Nevertheless, we are reasonably confident that the small alterations in blood pressure resulting from either drug were insufficient to cause changes in aortic size of a magnitude sufficient to be resolved by echocardiography.
There is still another consideration concerning flow measurement. The conversion of flow velocity to volume flow assumes that the velocity profile is reasonably flat across the portion of the aortic root in which the flow transducer was located. If this is the case, the position of the flow sensor in the cross-section of the aorta where the flow is measured should not cause more than a 15% variation in volume flow. 46 The aortic flow profile has been shown to be flat in the normal aorta.46,47 Studies in casts and models of the ascending aorta48,49 also have shown that the flow profiles are reasonably flat up to the point that the aorta begins to curve before the takeoff of the great vessels at the top of the arch. We do not know for certain that this is also the case in the abnormal aortic root in Marfan's syndrome. Because the ascending aorta in this disease, even though markedly dilated, is still reasonably straight and because the flow sensor was always positioned proximal to the origin of the great vessels, we suspect that the situation should be similar to that in a normal aorta. A flat profile is observed either in the entry region of a system before the profile is fully developed or in regions where the flow velocity is sufficiently high to result in turbulent rather than laminar flow. In the normal aortic root, the flat flow profile probably results from both of the above factors. The Marfan aorta usually rapidly tapers from just above the sinuses to a relatively normal size at the arch, so the flow would be accelerated in the region of the flow sensor compared with the normal aorta. This is another factor that would tend to maintain a flat velocity profile. For all of the above reasons, we suspect that the flow velocity in these patients was still reasonably flat and that the resulting volume flow estimation is reasonably accurate. This is speculation, however, until proved by direct measurement.
Finally, because of the abnormal geometry of the ascending aorta in these patients, it is difficult to determine exactly where the diameter is being measured by echocardiography even with the aid of two-dimensional cross-sectional imaging. In addition, the position of the flow sensor and the plane of the echocardiographic imaging may not have been the same, particularly in those patients in which the catheter tip was not in the left ventricle. Thus, the absolute magnitude of the volume flow could be in error, but because the patients served as their own controls in the drug interventions and because the catheter was not moved during the study, our conclusions should still be valid.
The hemodynamic indexes after 13-blockade observed in this study are measures only of the short-term effects of the drug and may not represent the situation in long-term administration of the drug. For example, a slight increase in aortic pressure after 13-blockade occurred as reported in our earlier study.27 This effect is not the usual nor desired response of long-term 13-blockade. Clearly, after long-term administration, many reflex and hormonal adjustments occur that may result in a different hemodynamic response from what we observed. In addition, it is perhaps equally important to study patients with Marfan's syndrome with only mild aortic root dilatation. The hemodynamic findings in such a group of patients may differ from those found here. One must keep these limitations in mind when interpreting the findings.
In summary, this study shows that the marked dilation and probable alterations in the mechanical properties of the aortic root of patients with Marfan's syndrome are manifested in the resting aortic impedance spectra. The primary abnormality consists of an increase in the magnitude of the wave reflections. This abnormality is ameliorated with vasodilation and exacerbated with short-term 13-blockade with propranolol administration. The baseline total arterial compliance is also increased with nitroprusside and decreased with 13-blockade.
Because propranolol increases wave reflections, does not reduce the peak acceleration of blood into the aortic root, and decreases arterial compliance, the left ventricle and aortic wall may be subjected to additional loading after 13-blockade. Thus, shortterm 13-blockade with propranolol may not necessarily produce the desired hemodynamic effects in patients with marked dilation of the aortic root.
